Literature DB >> 23270797

Synthetic tripeptides as alternate substrates of murein peptide ligase (Mpl).

Mireille Hervé1, Andreja Kovač, Cécile Cardoso, Delphine Patin, Boris Brus, Hélène Barreteau, Dominique Mengin-Lecreulx, Stanislav Gobec, Didier Blanot.   

Abstract

Murein peptide ligase (Mpl) is an enzyme found in Gram-negative bacteria. It catalyses the addition of tripeptide L-Ala-γ-D-Glu-meso-diaminopimelate to nucleotide precursor UDP-N-acetylmuramic acid during the recycling of peptidoglycan. Although not essential, this enzyme represents an interesting target for antibacterial compounds through the synthesis of alternate substrates whose incorporation into peptidoglycan might be deleterious for the bacterial cell. Therefore, we have synthesised 10 tripeptides L-Ala-γ-D-Glu-Xaa in which Xaa represents amino acids different from diaminopimelic acid. Tripeptide with Xaa = ε-D-Lys proved to be an excellent substrate of Escherichia coli Mpl in vitro. Tripeptides with Xaa = p-amino- or p-nitro-L-phenylalanine were poor substrates, while tripeptides with Xaa = D- or L-2-aminopimelate, DL-2-aminoheptanoic acid, L-Glu, L-norleucine, L-norvaline, L-2-aminobutyric acid or L-Ala were not substrates at all. Although a good Mpl substrate, the D-Lys-containing tripeptide was devoid of antibacterial activity against E. coli, presumably owing to poor uptake.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270797     DOI: 10.1016/j.biochi.2012.12.011

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

Review 1.  Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance.

Authors:  David A Dik; Jed F Fisher; Shahriar Mobashery
Journal:  Chem Rev       Date:  2018-05-30       Impact factor: 60.622

2.  Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins.

Authors:  Gabriel Torrens; Isabel M Barceló; Marcelo Pérez-Gallego; Maria Escobar-Salom; Sara Tur-Gracia; Marta Munar-Bestard; María Del Mar González-Nicolau; Yoandy José Cabrera-Venegas; Estefany Nayarith Rigo-Rumbos; Gabriel Cabot; Carla López-Causapé; Estrella Rojo-Molinero; Antonio Oliver; Carlos Juan
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

3.  Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target.

Authors:  Arundhati Maitra; Syamasundari Nukala; Rachael Dickman; Liam T Martin; Tulika Munshi; Antima Gupta; Adrian J Shepherd; Kristine B Arnvig; Alethea B Tabor; Nicholas H Keep; Sanjib Bhakta
Journal:  JAC Antimicrob Resist       Date:  2021-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.